文献速递血栓与止血

基于人群的队列研究中SERPINA1罕见与常见变异决定的血栓风险

Thrombotic risk determined by rare and common SERPINA1 variants in a population-based cohort study.
PubMed 文献 · J Thromb Haemost · 2022-03-19

在瑞典马尔默饮食与癌症研究(1991-1996)28,794名既往无静脉血栓栓塞(VTE)的参与者中分析SERPINA1编码序列,随访至2018年。结果显示Z等位基因纯合(ZZ)及Z变异与罕见合格变异的复合杂合与VTE风险升高相关,调整后风险比为4.5(95%CI 2.0-10.0),S变异与VTE无关联。

要点

  • SERPINA1 Z等位基因纯合增加VTE风险,杂合无影响。
  • Z变异与罕见合格变异组合的调整HR为4.5(95%CI 2.0-10.0)。
  • S变异(rs17580)与VTE无关联。

核心结论

  • SERPINA1 ZZ基因型及严重α1-抗胰蛋白酶缺乏症复合杂合在瑞典人群中罕见但与VTE相关。

研究设计与样本

  • 基于人群的队列研究,纳入Malmö Diet and Cancer研究(1991-1996)中28,794名既往无VTE的受试者(生于1923-1950年,60%为女性),随访至2018年。

主要发现

  • SERPINA1编码序列重测序共鉴定84个变异,包括21个同义、62个错义和1个功能缺失变异。
  • Kaplan-Meier分析显示Z等位基因纯合增加VTE风险,杂合无影响;S变异(rs17580)与VTE无关联。
  • 31个罕见合格变异纳入塌陷分析,选择标准为功能缺失、框内缺失或MAF<0.1%的非良性(PolyPhen-2)错义变异。
  • Z变异与罕见合格变异组合的两个等位基因携带者(ZZ或复合杂合)风险增加,Cox回归调整HR为4.5(95%CI 2.0-10.0)。
  • 另一变异rs141620200(MAF=0.002)显示VTE风险增加。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Severe alpha-1-antitrypsin deficiency (AATD), phenotype PiZZ, was associated with venous thromboembolism (VTE) in a case-control study. OBJECTIVES: This study aimed to determine the genetic variation in the SERPINA1 gene and a possible thrombotic risk of these variants in a population-based cohort study. PATIENTS/METHODS: The coding sequence of SERPINA1 was analyzed for the Z (rs28929474), S (rs17580), and other qualifying variants in 28,794 subjects without previous VTE (born 1923-1950, 60% women), who participated in the Malmö Diet and Cancer study (1991-1996). Individuals were followed from baseline until the first event of VTE, death, or 2018. RESULTS: Resequencing the coding sequence of SERPINA1 identified 84 variants in the total study population, 21 synonymous, 62 missense, and 1 loss-of-function variant. Kaplan-Meier analysis showed that homozygosity for the Z allele increased the risk of VTE whereas heterozygosity showed no effect. The S (rs17580) variant was not associated with VTE. Thirty-one rare variants were qualifying and included in collapsing analysis using the following selection criteria, loss of function, in frame deletion or non-benign (PolyPhen-2) missense variants with minor allele frequency (MAF) <0.1%. Combining the rare qualifying variants with the Z variant showed that carrying two alleles (ZZ or compound heterozygotes) showed increased risk. Cox regression analysis revealed an adjusted hazard ratio of 4.5 (95% confidence interval 2.0-10.0) for combinations of the Z variant and rare qualifying variants. One other variant (rs141620200; MAF = 0.002) showed an increased risk of VTE. CONCLUSIONS: The SERPINA1 ZZ genotype and compound heterozygotes for severe AATD are rare but associated with VTE in a population-based Swedish study.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Manderstedt E, Halldén C, Lind-Halldén C, et al. Thrombotic risk determined by rare and common SERPINA1 variants in a population-based cohort study. J Thromb Haemost. 2022. PMID: 35263815. doi:10.1111/jth.15696

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。